Drugs / Immune Globulin Infusion 10% (Human)
Immune Globulin Infusion 10% (Human)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03277313 | Sep 2017 → Jul 2022 | immunodeficiency disease | Baxalta now part of Shire | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Immune Globulin Infusion 10% (Human) | “Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase (IGI, 10% with rHuPH20)” NCT03277313 ↗ |
| Modality | Protein / enzyme biologic | “Immune Globulin Infusion 10% (Human)” NCT03277313 ↗ |